D Mattei Selected Research

D Mattei Research Topics

2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2014 - 12/2003
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2004 - 12/2002
2	Malaria 10/2001 - 11/2000
1	Sleepiness 01/2017
1	Mental Disorders (Mental Disorder) 01/2017
1	Residual Neoplasm 07/2014
1	Membranous Glomerulonephritis (Membranous Nephropathy) 06/2010
1	Pulmonary Arterial Hypertension 06/2009
1	Invasive Fungal Infections 11/2007
1	Second Primary Neoplasms (Neoplasms, Second) 03/2004
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2003
1	Fungemia 12/2003
1	Aspergillosis 12/2002
1	Agranulocytosis (Granulocytopenia) 03/2001
1	Infections 03/2001
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2001

2	Voriconazole (Vfend)FDA LinkGeneric 12/2003 - 12/2002
2	Proteins (Proteins, Gene)FDA Link 10/2001 - 11/2000
1	Minocycline (Cyclops)FDA LinkGeneric 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Rituximab (Mabthera)FDA Link 06/2010
1	Dasatinib (BMS 354825)FDA Link 06/2009
1	liposomal amphotericin B FDA Link 12/2002
1	Itraconazole (Sporanox)FDA LinkGeneric 12/2002
1	deoxycholate drug combination amphotericin BIBA 12/2002
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2001
1	fludarabineIBA 03/2001
1	Mitoxantrone (Novantrone)FDA LinkGeneric 03/2001
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2001
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2001
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2001
1	AntibodiesIBA 11/2000

2	Hematopoietic Stem Cell Transplantation 07/2014 - 11/2007
1	Transplantation 11/2007
1	Aftercare (After-Treatment) 03/2004
1	Drug Therapy (Chemotherapy) 12/2003
1	Remission Induction 12/2002
1	Therapeutics 12/2002
1	Stem Cell Transplantation 12/2002
1	Antibiotic Prophylaxis 03/2001